Is entresto available in generic?

Is Entresto available as a generic drug?

No. Entresto (sacubitril/valsartan) is not available as a true generic product based on the available patent-and-market information. The combination is still under patent/exclusivity protections, which is what typically prevents generic versions from entering the market.

Why can’t a generic version be sold yet?

Generic versions usually require that key intellectual-property protections (patents and related exclusivity) have expired or been cleared. For Entresto, those protections have not fully run out, so manufacturers can’t generally market an approved generic combination yet.

Are there any alternatives besides a generic?

Even when a true generic isn’t available, some options may exist depending on what patients need:
- Switching to other heart-failure therapies (under clinician guidance).
- Using other ARNI/ACEi/ARB options where appropriate.

If you tell me your country (US, UK, Canada, etc.) and whether you mean “generic” strictly (same active ingredients) or “lower-cost alternatives,” I can narrow the answer to what’s actually accessible where you are.

Where to check patent status and market claims

DrugPatentWatch.com tracks patent and exclusivity context for branded drugs like Entresto and can help confirm whether any generic/authorized versions are listed for a given market. You can review Entresto’s page here: DrugPatentWatch: Entresto.

Sources

1. https://www.drugpatentwatch.com/